1285607-08-0
1285607-08-0
Chemical Structure
Fexlamose
Synonym(s): AER-01; MUC-031
- No. CAS: 1285607-08-0
- Formula:C12H22O9S2
- Molecular Weight:374.43
InChIKey: LVLYFBOCRJBHIZ-LIZSDCNHSA-N
SMILES: SC[C@H]([C@H]([C@@H]([C@H]1O)O)O)O[C@@H]1O[C@H]2O[C@@H]([C@H]([C@@H]([C@H]2O)O)O)CS
Biological Activity: Fexlamose (AER-01) is a thiol-modified carbohydrate agent with mucolytic property. Fexlamose cleaves disulfides to cause mucolysis. Fexlamose can be used for researchs of chronic obstructive pulmonary disease (COPD) and muco-obstructive lung diseases (MOLD)[1][2].
| Referencia número | Nombre del producto | Pureza | Descripciòn | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fexlamose | 99.93% | Fexlamose (AER-01) is a thiol-modified carbohydrate agent with mucolytic property. Fexlamose cleaves disulfides to cause mucolysis. Fexlamose can be used for researchs of chronic obstructive pulmonary disease (COPD) and muco-obstructive lung diseases (MOLD). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Vu SP, et al., Molecular Approaches to Treating Chronic Obstructive Pulmonary Disease: Current Perspectives and Future Directions. Int J Mol Sci. 2025 Feb 28;26(5):2184. [Content Brief]
- [2]. Addante A, et al. A. A novel thiol-saccharide mucolytic for the treatment of muco-obstructive lung diseases. Eur Respir J. 2023 May 25;61(5):2202022. [Content Brief]
Keywords
